Rebecca Womack
Adult Health · Melbourne, FLNPI 1942470612
Payments from drug & device makers
Across 225 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$714
- Lilly USA, LLC$435
- AbbVie$429
- AstraZeneca$425
- Boehringer Ingelheim$396
- Bayer$279
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,106100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $714 |
| Lilly USA, LLC | 22 | $435 |
| AbbVie(2 entities) | 29 | $429 |
| AstraZeneca | 22 | $425 |
| Boehringer Ingelheim | 19 | $396 |
| Bayer | 13 | $279 |
| Johnson & Johnson | 16 | $270 |
| Pfizer | 12 | $237 |
| Amgen | 11 | $195 |
| Novartis | 4 | $77 |
| Esperion Therapeutics, Inc. | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Exact Sciences | 3 | $66 |
| GSK | 3 | $65 |
| Abbott | 3 | $65 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Corcept Therapeutics | 2 | $46 |
| Arbor Pharmaceuticals, Inc. | 3 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Mannkind Corporation | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Boston Scientific | 1 | $21 |
| Corium, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Athena Bioscience, LLC | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
How this compares
$4,106 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 24 | $47,006 |
| OzempicSemaglutide | 27 | $40,676 |
| JardianceEmpagliflozin | 19 | $26,086 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $16,632 |
| XareltoRivaroxaban | 15 | $14,675 |
| FarxigaDapagliflozin Propanediol | 13 | $7,329 |
| Levothyroxine Sodium | 109 | $1,530 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,495 |
| Amlodipine Besylate | 134 | $1,406 |
| Rosuvastatin Calcium | 88 | $1,202 |
| Ezetimibe | 41 | $1,163 |
| Losartan Potassium | 82 | $1,121 |
| Omeprazole | 58 | $1,084 |
| Atorvastatin Calcium | 78 | $1,026 |
| Valsartan | 23 | $931 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $714 | $87,68251 claims |
| Boehringer IngelheimJardiance | $396 | $26,08619 claims |
| GSKTrelegy Ellipta | $65 | $16,63216 claims |
| Johnson & JohnsonXarelto | $270 | $14,67515 claims |
| AstraZenecaFarxiga | $425 | $7,32913 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $32 | $1,530109 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,237 adult health providers in Florida.
Other adult health in Melbourne
- Melissa StudebakerMelbourne$16K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.